Mutants of the leucine‐rich repeat kinase 2 (LRRK2) and the PTEN‐inducible kinase 1 (PINK1) can profoundly impact organelle physiology contributing to PD pathogenesis and progression. Here, PINK1 is linked to Parkinson disease.